Carson Wealth (CWM LLC)’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107K Buy
34,760
+33,349
+2,364% +$144K ﹤0.01% 3208
2025
Q4
$5K Sell
1,411
-1,741
-55% -$10.7K ﹤0.01% 4794
2025
Q3
$28K Sell
3,152
-330
-9% -$3.35K ﹤0.01% 3916
2025
Q2
$32K Buy
3,482
+364
+12% +$3.11K ﹤0.01% 3602
2025
Q1
$27K Buy
3,118
+31
+1% +$293 ﹤0.01% 3455
2024
Q4
$33K Sell
3,087
-363
-11% -$2.79K ﹤0.01% 3095
2024
Q3
$20K Buy
3,450
+2,104
+156% +$12.1K ﹤0.01% 3341
2024
Q2
$6K Buy
1,346
+1,166
+648% +$4.72K ﹤0.01% 3748
2024
Q1
$1K Sell
180
-65
-27% -$366 ﹤0.01% 4073
2023
Q4
$2K Sell
245
-413
-63% -$2.84K ﹤0.01% 3776
2023
Q3
$4K Buy
658
+247
+60% +$1.97K ﹤0.01% 3530
2023
Q2
$3K Sell
411
-25
-6% -$214 ﹤0.01% 3600
2023
Q1
$4K Buy
436
+350
+407% +$3.49K ﹤0.01% 3355
2022
Q4
$1K Buy
+86
New +$919 ﹤0.01% 3689
2022
Q1
Sell
-28
Closed 3516
2021
Q4
$0 Buy
+28
New +$532 ﹤0.01% 3487
2021
Q2
$5K Hold
200
﹤0.01% 2339
2021
Q1
$5K Hold
200
﹤0.01% 2339
2020
Q4
$5K Hold
200
﹤0.01% 2339
2020
Q3
$5K Hold
200
﹤0.01% 2339
2020
Q2
$5K Hold
200
﹤0.01% 2338
2020
Q1
$5K Hold
200
﹤0.01% 2338
2019
Q4
$5K Hold
200
﹤0.01% 2338
2019
Q3
$5K Hold
200
﹤0.01% 2338
2019
Q2
$5K Hold
200
﹤0.01% 2338
2019
Q1
$5K Sell
200
-5,800
-97% -$13.9K ﹤0.01% 2337
2018
Q4
$9K Buy
+6,000
New +$13.6K ﹤0.01% 1355

Other funds holding AVXL

Carson Wealth (CWM LLC)'s AVXL Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Anavex Life Sciences (AVXL) stake by 2,364% in Q1 2026, buying an estimated $144K and bringing the position to 34,760 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #3208.

Carson Wealth (CWM LLC) first reported a position in AVXL in Q4 2018 and has held it in 26 quarters since. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Carson Wealth (CWM LLC) held 34,760 shares of Anavex Life Sciences worth $107K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 33,349 Anavex Life Sciences shares in Q1 2026, an estimated $144K.
  • Anavex Life Sciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3208 holding.
  • Carson Wealth (CWM LLC) first reported a position in Anavex Life Sciences in Q4 2018 and has held it in 26 quarters since.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.